These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38983711)

  • 61. Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy.
    Benning L; Mantsios A; Kerrigan D; Coleman JS; Golub E; Blackstock O; Konkle-Parker D; Philbin M; Sheth A; Adimora AA; Cohen MH; Seidman D; Milam J; Kassaye SG; Taylor T; Murray M
    BMC Womens Health; 2020 Jul; 20(1):152. PubMed ID: 32711509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluating the quality of HIV epidemiologic evidence for populations in the absence of a reliable sampling frame: a modified quality assessment tool.
    Rao A; Schwartz S; Viswasam N; Rucinski K; Van Wickle K; Sabin K; Wheeler T; Zhao J; Baral S
    Ann Epidemiol; 2022 Jan; 65():78-83. PubMed ID: 34314845
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peer community health workers improve HIV testing and ART linkage among key populations in Zambia: retrospective observational results from the Z-CHECK project, 2019-2020.
    Lindsay BR; Mwango L; Toeque MG; Malupande SL; Nkhuwa E; Moonga CN; Chilambe A; Sakala H; Kafunda I; Olowski P; Olufunso A; Okuku J; Kancheya N; Mumba D; Hachaambwa L; Sheneberger R; Blanco N; Lavoie MC; Claassen CW
    J Int AIDS Soc; 2022 Nov; 25(11):e26030. PubMed ID: 36317821
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized controlled trial of an mHealth intervention for increasing access to HIV testing and care among young cisgender men and transgender women: the mLab App study protocol.
    Wood OR; Garofalo R; Kuhns LM; Scherr TF; Zetina APM; Rodriguez RG; Nash N; Cervantes M; Schnall R
    BMC Public Health; 2021 Oct; 21(1):1959. PubMed ID: 34715833
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.
    Jaeger H; Overton ET; Richmond G; Rizzardini G; Andrade-Villanueva JF; Mngqibisa R; Hermida AO; Thalme A; Belonosova E; Ajana F; Benn PD; Wang Y; Hudson KJ; Español CM; Ford SL; Crauwels H; Margolis DA; Talarico CL; Smith KY; van Eygen V; Van Solingen-Ristea R; Vanveggel S; Spreen WR
    Lancet HIV; 2021 Nov; 8(11):e679-e689. PubMed ID: 34648734
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coverage of immediate postpartum long-acting reversible contraception has improved birth intervals for at-risk populations.
    Liberty A; Yee K; Darney BG; Lopez-Defede A; Rodriguez MI
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S886.e1-S886.e9. PubMed ID: 31846612
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Integration of Gender-Affirming Primary Care and Peer Navigation With HIV Prevention and Treatment Services to Improve the Health of Transgender Women: Protocol for a Prospective Longitudinal Cohort Study.
    Lama JR; Mayer KH; Perez-Brumer AG; Huerta L; Sanchez H; Clark JL; Sanchez J; Reisner SL
    JMIR Res Protoc; 2019 Jun; 8(6):e14091. PubMed ID: 31250829
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV prevention and HIV care among transgender and gender diverse youth: design and implementation of a multisite mixed-methods study protocol in the U.S.
    Jadwin-Cakmak L; Reisner SL; Hughto JMW; Salomon L; Martinez M; Popoff E; Rivera BA; Harper GW
    BMC Public Health; 2019 Nov; 19(1):1531. PubMed ID: 31730450
    [TBL] [Abstract][Full Text] [Related]  

  • 69. University of North Carolina/Emory Center for Innovative Technology (iTech) for Addressing the HIV Epidemic Among Adolescents and Young Adults in the United States: Protocol and Rationale for Center Development.
    Hightow-Weidman LB; Muessig K; Rosenberg E; Sanchez T; LeGrand S; Gravens L; Sullivan PS
    JMIR Res Protoc; 2018 Aug; 7(8):e10365. PubMed ID: 30076126
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association of Medicaid expansion with health insurance, unmet need for medical care and substance use disorder treatment among people who inject drugs in 13 US states.
    Cooper H; Beane S; Yarbrough C; Haardörfer R; Ibragimov U; Haley D; Linton S; Beletsky L; Landes S; Lewis R; Peddireddy S; Sionean C; Cummings J;
    Addiction; 2024 Mar; 119(3):582-592. PubMed ID: 38053235
    [TBL] [Abstract][Full Text] [Related]  

  • 71. People Who Inject Drugs in Mozambique: We need to normalize HIV treatment and care services in specialized community centers for people who inject drugs!
    Semá Baltazar C; Ribeiro Banze A; Seleme J; Boothe M
    Harm Reduct J; 2024 Jan; 21(1):6. PubMed ID: 38184600
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
    Margolis DA; Gonzalez-Garcia J; Stellbrink HJ; Eron JJ; Yazdanpanah Y; Podzamczer D; Lutz T; Angel JB; Richmond GJ; Clotet B; Gutierrez F; Sloan L; Clair MS; Murray M; Ford SL; Mrus J; Patel P; Crauwels H; Griffith SK; Sutton KC; Dorey D; Smith KY; Williams PE; Spreen WR
    Lancet; 2017 Sep; 390(10101):1499-1510. PubMed ID: 28750935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Contribution of cabotegravir + rilpivirine long-acting for the treatment of HIV-1 infection.
    Calleja-Hernández MÁ; Martinez-Sesmero JM; Vallejo-Aparicio LA; Hernández-Novoa B; Badia X
    Farm Hosp; 2022 Jul; 46(4):208-214. PubMed ID: 36183218
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CROI 2014: New tools to track the epidemic and prevent HIV infections.
    Buchbinder SP; Liu AY
    Top Antivir Med; 2014 May; 22(2):579-93. PubMed ID: 24901884
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in Cambodia.
    Saing CH; Prem K; Uk P; Chhoun P; Chann N; Tuot S; Mun P; Yi S
    Int J Drug Policy; 2020 Oct; 86():102974. PubMed ID: 33068831
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH).
    Mora M; Goodyear T; Marcellin F; Shoveller J; Di Beo V; Calzolaio C; Sogni P; Wittkop L; Zucman D; Poizot-Martin I; Lacombe K; Salmon-Céron D; Knight R; Carrieri P
    J Viral Hepat; 2020 Dec; 27(12):1462-1472. PubMed ID: 32810905
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Longitudinal Cohort Study of Gender Affirmation and HIV-Related Health in Transgender and Gender Diverse Adults: The LEGACY Project Protocol.
    Reisner SL; Deutsch MB; Mayer KH; Potter J; Gonzalez A; Keuroghlian AS; Hughto JM; Campbell J; Asquith A; Pardee DJ; Pletta DR; Radix A
    JMIR Res Protoc; 2021 Mar; 10(3):e24198. PubMed ID: 33646126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.
    Grillon C; Krishtel PR; Mellouk O; Basenko A; Freeman J; Mendão L; Andrieux-Meyer I; Morin S
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25060. PubMed ID: 29633580
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment and Prevention for People Experiencing Homelessness.
    Mehtani NJ; Strough A; Strieff S; Zevin B; Eveland J; Riley ED; Gandhi M
    J Acquir Immune Defic Syndr; 2024 May; 96(1):61-67. PubMed ID: 38346426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.